2023
Exports
$1.23MWorld Rnk 98 / 208
Flag Rnk 554 / 1123
2023
PRODUCT COMPLEXITY IN Vaccines, blood, antisera, toxins and cultures
1.25Rnk 89 / 1025
2023
Imports
$498MWorld Rnk 48 / 222
Flag Rnk 51 / 1202
2023
ECONOMIC COMPLEXITY of Philippines
0.64Rnk 40 / 132

About

Exports In 2023, Philippines exported $1.23M in Vaccines, blood, antisera, toxins and cultures, making it the 98th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 554th most exported product in Philippines. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Philippines are: Hong Kong ($465k), Russia ($188k), China ($143k), Vietnam ($96.4k), and Belgium ($85.1k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Philippines between 2022 and 2023 were Russia ($188k), China ($82.9k), and Vietnam ($79.1k).

Imports In 2023, Philippines imported $498M in Vaccines, blood, antisera, toxins and cultures, becoming the 48th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 51st most imported product in Philippines. Philippines imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($146M), India ($56.8M), Switzerland ($46.6M), France ($38.3M), and Germany ($36.7M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Philippines between 2022 and 2023 were Switzerland ($26.4M), India ($24.5M), and Sweden ($10.3M).

Latest Trends

May 2024

Subnational Monthly Trade

Time Scale
Flow
Color
EXPORT GROWTH (June 2022 - May 2024)$2.06k(159%)
IMPORT GROWTH (July 2023 - July 2024)$-985k(-2.22%)
MAIN DESTINATION (May 2024)

This section shows Vaccines, blood, antisera, toxins and cultures's exports and imports data at subnational level for Philippines. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, blood, antisera, toxins and cultures over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2023)$1.23M
IMPORTS (2023)$498M
NET TRADE (2023)-$497M

In 2023, Philippines exported $1.23M in Vaccines, blood, antisera, toxins and cultures. The main destinations of Philippines exports on Vaccines, blood, antisera, toxins and cultures were Hong Kong ($465k), Russia ($188k), China ($143k), Vietnam ($96.4k), and Belgium ($85.1k).

In 2023, Philippines imported $498M in Vaccines, blood, antisera, toxins and cultures, mainly from United States ($146M), India ($56.8M), Switzerland ($46.6M), France ($38.3M), and Germany ($36.7M).

Explore Visualizations

Export Destinations (2023)

Import Origins (2023)

Market Growth

Flow
THE FASTEST GROWING Vaccines, blood, antisera, toxins and cultures EXPORT MARKETS FOR Philippines WERE (2022 - 2023):
Russia$188k (1%)
China$82.9k (139%)
Vietnam$79.1k (459%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Vaccines, blood, antisera, toxins and cultures BY Philippines WERE (2022 - 2023):
Singapore-$758k (-91.7%)
South Korea-$70.9k (-100%)
Panama-$14.5k (-49.5%)

Change in Exports by Market (2022 - 2023)

Market Concentration

View
Flow
Type
In 2023, Philippines's main exporting competitors in Vaccines, blood, antisera, toxins and cultures were:
In 2023, Philippines's main importing competitors in Vaccines, blood, antisera, toxins and cultures were:

Explore Visualizations

Trade Value of Vaccines, blood, antisera, toxins and cultures by Exporters

Potential Exports

Potential Exports

Flow
View
TOP EXPORT POTENTIALSingapore+ $490k
TOP IMPORT POTENTIALUnited States+ $41.9M

Vaccines, blood, antisera, toxins and cultures’s highest export potential is Singapore. With an export gap of $490k.   Vaccines, blood, antisera, toxins and cultures’s highest import potential is United States with an import gap of $41.9M.

See methodology.

Subscribe today to OEC pro and access the latest data

Sign Up

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with